￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
028-123456789
Menu

medicaldrugs

Efficacy and case studies of pitubrutinib/pitobrutinib (Zepali) in the treatment of lymphoma

2026-02-01 22:25:32

Check Details
Do patients with prostate cancer need long-term medication when using talazoparib (Tazena)?

2026-02-01 22:25:32

Check Details
Explanation of differences between producing countries and importing countries of Crizotinib

2026-02-01 22:25:32

Check Details
Can aprocitentan be discontinued suddenly and the possible risks caused by discontinuation

2026-02-01 22:25:32

Check Details
Precautions for use of tilpotide/tilsiparatide (Mufenda) and safety guide for daily medication

2026-02-01 22:25:32

Check Details
Pitobrutinib/Pitobrutinib (Zepali) drug basic information and main parameter description

2026-02-01 22:25:32

Check Details
Price reference and purchase method of Talazoparib in the Canadian market

2026-02-01 22:25:32

Check Details
Analysis of whether crizotinib (Xalkori) is the last hope for patients and its clinical choice

2026-02-01 22:25:32

Check Details
Remedies for missed doses of aprocitentan and tips to avoid blood pressure fluctuations

2026-02-01 22:25:32

Check Details
Recommendations for the use of tilpotide/tirsiparatide (Mufenda) in special populations

2026-02-01 22:25:32

Check Details
Pitobrutinib/Pitobrutinib (Zepali) generally requires several courses of treatment to be effective

2026-02-01 22:25:32

Check Details
The best daily taking time and medication precautions for Talazoparib (Tazena)

2026-02-01 22:25:32

Check Details
Category
相关知识